Last Tuesday's breaking news of cannabis rescheduling drove the cannabis industry into overdrive with elated thoughts from tax relief to soaring marijuana stocks to cannabis scientists presuming they no longer have to keep their research…
The DEA was expected to move forward with its plans this week to remove cannabis as a Schedule 1 drug, where it currently sits alongside heroin and LSD, but new reports suggest the proposal has stalled.
The Nasdaq stock exchange is “warming up” to the idea of continuing to list Canadian cannabis companies even if they have exposure to the U.S. market — and a U.S. cannabis company could be next, an analyst at Jefferies said.
"Cannabis is just getting started and there's going to be a lot of companies getting ready to take advantage of this massive growth cycle, government reform, news states, opening new opportunities and one day, interstate commerce." That's…
Canopy Growth Corp., Tilray Brands Inc. and Curaleaf Holdings Inc. were among cannabis stocks that were sliding into the red on Wednesday, a day after news of the federal government’s plans to reclassify marijuana.
Cannabis stocks Canopy Growth Corporation (NASDAQ:CGC), Aurora Cannabis, Inc. (NASDAQ:ACB) and Tilray Brands, Inc. (NASDAQ:TLRY) shares are trading lower Wednesday after soaring following reports that the DEA will move to reschedule…
Cannabis stocks soared Tuesday following reports that the DEA will move to reschedule marijuana from a Schedule I to a Schedule III substance. IM Cannabis shares are holding the gains, while larger weed stocks including Canopy Growth…
Tuesday's news that the Drug Enforcement Agency (DEA) will move to reclassify marijuana as a less dangerous drug blew the industry and sent cannabis stocks high in the sky. And, while the move was generally praised by the majority of…
In a historic trading session on Tuesday, cannabis stocks soared following the DEA's reported decision to reclassify marijuana from Schedule I to Schedule III under the Controlled Substances Act.
With the DEA set to reclassify marijuana as a less dangerous drug, weed companies will finally get a break from a punitive federal tax rate—and cannabis stocks have already rallied.
Cannabis stocks were up sharply on Tuesday on a report by the Associated Press that the U.S. Drug Enforcement Administration is poised to propose moving cannabis to a Schedule III controlled substance.
The cannabis sector saw a notable upswing on Tuesday on news of the Drug Enforcement Administration's (DEA) historic decision to align its stance with a recommendation from the Department of Health and Human Services and move read more
The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, the Associated Press reported on Tuesday early afternoon, calling it a "historic shift to generations of American drug policy that could…
Decibel Cannabis Company reported on Monday its audited financial results for the three and twelve month periods ending Dec. 31, 2023. The Calgary, Alberta-based company said it saw a record net revenue of CA$116 million ($84.8 million) in…